G. De Brabanter

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

Patrick Verschueren, Diederik De Cock, Luk Corluy et al. · Annals of the Rheumatic Diseases · 2014 · 124 citations · Full text

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial

Patrick Verschueren, Diederik De Cock, Luk Corluy et al. · Annals of the Rheumatic Diseases · 2016 · 114 citations

An induction or flare of arthritis and/or sacroiliitis by vedolizumab in inflammatory bowel disease: a case series

Gaëlle Varkas, Kristof Thevissen, G. De Brabanter et al. · Annals of the Rheumatic Diseases · 2016 · 107 citations

Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial

Patrick Verschueren, Diederik De Cock, Luk Corluy et al. · Arthritis Research & Therapy · 2015 · 42 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +7

Efficacy and tolerability of sustained-release ibuprofen in the treatment of patients with chronic back pain

Marc Driessens, Jean Pierre Famaey, Serge Orloff et al. · Current Therapeutic Research · 1994 · 16 citations

Pain Therapy, Health Sciences, Pain Medicine +10